Faculty of Medicine

Mixed Up Cell Transportation Key Piece of ALS and Dementia Puzzle

Oct 5, 2015
Katie Babcock
Professor Janice Robertson and Shangxi XiaoIt’s the most common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), but until now scientists weren’t sure how a specific gene caused these devastating diseases. Now researchers from the University of Toronto are one step closer to solving this incredibly complex puzzle, offering hope for treatment.

“Researchers knew that mutations in a specific gene caused 40 per cent of inherited cases of ALS, but there are few studies of the normal function of this gene,” said Janice Robertson, professor in the Faculty of Medicine’s Department of Laboratory Medicine and Pathobiology. “Other scientists have focused on how the gene’s mutation causes disease. We’ve developed the first antibodies to track what this gene does in both a normal and diseased cell.”

Using these antibodies, Robertson and her team tracked proteins from the key gene, C9orf72. They discovered that a specific protein from this gene might help transport other essential proteins in and out of a motor neuron cell’s nucleus, the command centre of the cell. Their findings were recently published in the Annals of Neurology.

Antibodies surround a healthy motor neuron cell (left) and move to the outer cell membrane in ALS (right).Antibodies surround a healthy motor neuron cell (left) and move to the outer cell membrane in ALS (right). “We saw that a protein from C9orf72 normally surrounds the nucleus of a motor neuron cell,” said Robertson, who is also a scientist at U of T’s Tanz Centre for Research in Neurodegenerative Diseases. “But in ALS or FTD, this protein moves to the outer membrane of the cell. When this protein is misplaced, it can’t help other proteins move in and out of the cell’s nucleus and the cell dies.”

This transportation normally depends on a cascade of events that acts like a relay race. DNA, the cell’s instructions, is converted into RNA which then makes proteins for the cell that allow it to carry out its functions. Just like a relay, when a protein from C9orf72 disappears from surrounding the nucleus, it can no longer help transport other essential proteins that keep the cell alive.

Next, the researchers want to understand how C9orf72 is involved in transporting these proteins and potentially target the pathway with drugs.

“This pathway is easily targeted with drugs that already exist,” said Dr. Shangxi Xiao, first author of the publication. “If we can restore function to this pathway and make proteins go back to the nucleus, we could develop treatment options.”

Robertson’s remarkable findings provide hope for treating ALS and FTD. ALS is a neuromuscular disease that begins as a mild muscle weakness and progresses to complete paralysis. Frontotemporal dementia is closely linked to ALS and leads to memory loss, behavior changes and difficulties with movement and speech.

James Hunter is one of our financial supporters, and he’s completely paralyzed,” said Robertson. “He uses his eyes to communicate through a computer program, but now his eyes have almost stopped moving — this is ALS.”

Robertson believes the impact of this and others’ research will revolutionize treatment for ALS and FTD. “Recently, there have been four important publications, all honing in on this specific pathway. We’re getting closer to finding treatment options,” she said. “We’d like to thank those involved in the James Hunter and Family ALS Initiative and the families who have donated tissues for research. Ultimately, our goal is to find a treatment for patients who desperately need more options.” 

Jun 21 Continuing Education Rounds: LDCT Lung Cancer Screening - Let’s Get Ready!
Grand Rounds | 8:00am–9:00am
Jun 22 Atherosclerosis in South Asians: Partnering for a Healthier Future
Symposium | 8:00am–3:00pm
Jun 25 Faculty of Medicine Staff Recognition BBQ
Other | 12:00pm–2:30pm
Jun 27 SEEDing Innovation: First Annual XSeed and EMHSeed Poster Session
Other | 1:00pm–3:00pm
Jul 3 WebPac Training
Workshop/Seminar | 2:00pm–3:30pm
11 – 14
International Society for the Advancement of Clinical MEG: Epilepsy and Beyond
Symposium | 7:00am–5:00pm
20 – 22
34th Annual Organ Imaging Review
Conference | 7:15am–5:15pm


UofT Medicine
RT : Does early consultation with a physical medicine and rehab doctor benefit people with traumatic injuries or burns?… https://t.co/HtXapRPb8h
UofT Medicine
Providing inclusive care to the trans community: Prof Thea Weisdorf & Nurse Practitioner Sue Hranilovic sp… https://t.co/SygefNsJt7
UofT Medicine
RT : From to immigrant integration: 56 researchers supported by Canada Research Chairs Program https://t.co/rqZhpfcJcB

UofTMed Magazine

Have we lost the art of dying?

Sign up for your free digital copy.